Gene test for newborns: could it spot hidden diseases?
NCT ID NCT05476640
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to see if targeted gene sequencing could improve newborn disease screening compared to standard methods. Over 3,300 newborns were tested, but the study was terminated early. The goal was to measure how well the genetic test agreed with routine screening results.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that genetic sequencing is a useful addition to standard newborn screening, helping detect more conditions early.
- What could go wrong
- The study was terminated early, so results are limited. It is an observational comparison, not a treatment trial, and may not change practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEWBORNS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Children's hospital
Shanghai, 200062, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.